Angiogenesis(血管生成)
- Cat.No. 产品名称 Information
-
GC47966
PPACK (trifluoroacetate salt)
Pebac, DPhenylalanylprolylarginyl Chloromethyl Ketone
An antithrombin peptide -
GC47965
Pomalidomide-d5
泊马度胺杂质,CC-4047-d5
An internal standard for the quantification of pomalidomide -
GC47582
Lupulone
蛇床酮
A beta-acid -
GC47454
IMS 2186
An anti-choroidal neovascularization agent
-
GC47398
Genistein-d4
金雀异黄酮-D4,NPI 031L-d4
An internal standard for the quantification of genistein -
GC47328
Everolimus-d4
RAD001-d4; SDZ-RAD-d4
An internal standard for the quantification of everolimus -
GC47298
Epalrestat-d5
A neuropeptide with diverse biological activities
-
GC47234
Diosmetin-d3
香叶木素 d3
An internal standard for the quantification of diosmetin -
GC47163
D-2-Aminoglutarimide (hydrochloride)
(R)-3-氨基-哌啶-2,6-二酮盐酸盐
A synthetic intermediate -
GC46986
C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3)
Ceramide-1-phosphate (d18:1/18:0-d3), CerP(d18:1/18:0-d3), N-octadecanoyl-D-erythro-Sphingosine-1-phosphate-d3
A neuropeptide with diverse biological activities -
GC46924
BIBF 1120-13C-d3
Nintedanib-13C-d3
A neuropeptide with diverse biological activities -
GC46899
Axitinib-13C-d3
阿昔替尼杂质,AG-013736 13CD3
An internal standard for the quantification of axitinib -
GC46583
3-Amino-2,6-Piperidinedione
3-氨基-2,6-哌啶二酮
An active metabolite of (±)-thalidomide -
GC46474
18-Deoxyherboxidiene
RQN-18690A
A bacterial metabolite with antiangiogenic activity -
GC46304
(±)-Nebivolol-d4 (hydrochloride)
A neuropeptide with diverse biological activities
-
GC61323
Tetrac
四碘甲状腺乙酸,Tetraiodothyroacetic acid; 3,3',5,5'-Tetraiodothyroacetic acid
Tetrac(Tetraiodothyroaceticacid),L-甲状腺素(T4)的天然衍生物,是甲状腺素整合素受体拮抗剂。Tetrac阻断T4和3,5,3'-triiodo-L-thyronine(T3)在整联蛋白αvβ3上甲状腺激素的细胞表面受体处的作用。Tetra具有抗血管生成和抗肿瘤活性。 -
GC61316
tcY-NH2 TFA
(trans-Cinnamoyl)-YPGKF-NH2 TFA
tcY-NH2TFA是选择性的大鼠的PAR4肽类拮抗剂。tcY-NH2TFA抑制凝血酶和AY-NH2诱导的大鼠血小板聚集。 -
GC61109
Natalizumab
那他珠单抗
Natalizumab是一种重组的人源化单克隆抗体,与α4β1-整联蛋白(α4β1-integrin)结合并阻断其与血管细胞粘附分子1(VCAM-1)的相互作用。Natalizumab可用于复发缓解型多发性硬化症和克罗恩氏病的研究。Natalizumab也可阻止淋巴细胞进入中枢神经系统,从而防止急性脱髓鞘复发。 -
GC60807
ENMD-1068 hydrochloride
6-氨基-1-[4-(3-甲基丁酰)哌嗪-1-基]己烷-1-酮,6-Amino-1-[4-(3-methyl-1-oxobutyl)-1-piperazinyl]-1-hexanone hydrochloride
ENMD-1068hydrochloride是一种具有抗血管生成和抗炎活性的选择性蛋白酶激活受体2(PAR2)拮抗剂。ENMD-1068hydrochloride可通过抑制TGF-β1/Smad信号转导而减少星状细胞活化和胶原蛋白表达。
-
GC60551
Acalabrutinib D4
ACP-196-d4
AcalabrutinibD4(ACP-196D4)是Acalabrutinib的一种氘代化合物。Acalabrutinib(ACP-196)是一种具有口服活性,不可逆的,高度选择性的第二代BTK抑制剂。 -
GC60311
PTUPB
PTUPB是一种新型的COX-2和sEH双抑制剂,IC50 值分别为 1.26 nM 和 0.9μM。
-
GC60200
ILK-IN-3
ILK-IN-3 is an integrin linked kinase (ILK) inhibitor with antitumor activity.
-
GC60197
Ibrutinib deacryloylpiperidine
伊布替尼中间体N-2,IBT4A
Ibrutinibdeacryloylpiperidine(IBT4A)是Ibrutinib的一种杂质。Ibrutinib是一种不可逆的选择性Btk抑制剂,IC50为0.5nM。 -
GC60117
Cyclo(-RGDfK) TFA
An inhibitor of αvβ3 integrin
-
GC60077
BIO5192 hydrate
BIO5192hydrate是一种选择性强的整合素α4β1(VLA-4)抑制剂(Kd<10pM)。BIO5192hydrate选择性地与α4β1(IC50=1.8nM)结合,选择性高过其他一系列整合素。BIO5192hydrate导致小鼠造血干细胞和祖细胞(HSPCs)的动员比基础水平增加30倍。
-
GC50642
LDV
LDV 是一种三肽,是 LDV-FITC 的非荧光类似物。
-
GC50537
FM19G11
FM19G11 是一种低氧诱导因子-1-α (HIF-1α) 抑制剂,在 HeLa 细胞中抑制低氧诱导的荧光素酶活性,IC50 为 80 nM。
-
GC50325
BOP
BOP 是一种有效和选择性的双重 α9β1/α4β1 整合素抑制剂,Kd 值在皮摩尔范围内。
-
GC50128
TC-S 7009
An inhibitor of HIF-2α PAS-B domain heterodimerization
-
GC50078
BIRT 377
BIRT 377 是一种有效的口服生物利用度抑制剂,可抑制细胞间粘附分子-1 (ICAM-1) 和淋巴细胞功能相关抗原-1 (LFA-1) 之间的相互作用,Ki 为 25.8 nM。
-
GC50075
BTT 3033
BTT 3033 是一种口服活性的 α2β1 (EC50: 130 nM) 构象选择性抑制剂,通过与 α2I 结构域结合。
-
GC39194
Ibrutinib D5
伊布替尼布D5,PCI-32765-d5
An internal standard for the quantification of ibrutinib -
GC39146
HIF-1 inhibitor-1
An inhibitor of HIF-1 signaling
-
GC38893
BMS-688521
BMS-688521 是一种高效、具有口服活性的 LFA-1/ICAM 相互作用抑制剂,在粘附试验中 IC50 为 2.5 nM,在 MLR 试验中 IC50 为 60 nM。BMS-688521 对小鼠变应性嗜酸性肺炎模型有较好的治疗作用。
-
GC38873
α2β1 Integrin Ligand Peptide TFA
α2β1 Integrin Ligand Peptide TFA 在细胞膜表面与 α2β1 整合素受体相互作用,进入细胞介导细胞外信号。α2β1 Integrin Ligand Peptide是一种潜在的胶原受体拮抗剂。
-
GC38801
Irigenin
野鸢尾黄素
An isoflavonoid with diverse biological activities -
GC38767
Deoxyshikonin
去氧紫草素
Deoxyshikonin 是从 Lithospermum erythrorhizon Sieb 中分离得到的,具有抗肿瘤活性。 -
GC38731
2-Furoyl-LIGRLO-amide TFA
2-Furoyl-LIGRLO-amide TFA 是一种有效的选择性蛋白酶激活受体2 (PAR2) 激动剂, 其 pD2 值为 7.0。
-
GC45922
(±)11(12)-EET-d11 methyl ester
(±)11,12-EpETrE-d11 methyl ester
A neuropeptide with diverse biological activities -
GC45880
Cimetidine-d3
西咪替丁-D3,SKF-92334-d3
An internal standard for the quantification of cimetidine -
GC45798
Rhein-13C4
1,8-二羟基-3-羧基蒽醌
An internal standard for the quantification of rhein
-
GC45769
Vandetanib-d6
ZD6474-d6
An internal standard for the quantification of vandetanib -
GC45767
Dovitinib-d8
多韦替尼 D8
An internal standard for the quantification of dovitinib -
GC45688
STX140
2-Methoxyestradiol-bis-sulphamate
An estrogen sulfamate -
GC38375
Remibrutinib
Remibrutinib (LOU064) is a potent, highly selective covalent inhibitor of bruton tyrosine kinase (BTK) with IC50 of 1.3 nM, 2.5 nM and 18 nM for BTK, FcγR-induced IL8 and anti-IgM/IL4-induced CD69, respectively. Remibrutinib (LOU064) exhibits an exquisite kinase selectivity due to binding to an inactive conformation of BTK and has the potential for the treatment of autoimmune diseases.
-
GC38329
GB-110 hydrochloride
GB-110 hydrochloride 是一种有效的,具有口服活性的,非肽类的 protease activated receptor 2 (PAR2) 激动剂。GB-110 hydrochloride 选择性诱导 PAR2 介导的 HT29 细胞内 Ca2+ 释放,EC50 值为 0.28 μM。
-
GC38128
c(phg-isoD-G-R-(NMe)k) TFA
c(phg-isoD-G-R-(NMe)k) TFA 是有效选择性的 α5β1 整合素 配体,IC50 为 2.9 nM。
-
GC38044
Fraxinellone
梣酮
A liminoid degradant with diverse biological activities -
GA23350
PAR-3 (1-6) amide (human)
A peptide agonist of PAR1 and PAR2
-
GC37975
α2β1 Integrin Ligand Peptide
α2β1 Integrin Ligand Peptide在细胞膜表面与 α2β1 整合素受体相互作用,进入细胞介导细胞外信号。α2β1 Integrin Ligand Peptide是一种潜在的胶原受体拮抗剂。